Insider holders · CIK 0001651308
BeOne Medicines Ltd. · ONC
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Hillhouse Capital Management, Ltd.10% Owner | — | 71,139,367 | 71,139,367 | Feb 1, 2018 · 5:15 pm EST | Form 3 |
| CB Biotech Investment Ltd10% Owner | 19,601,138 | — | 19,601,138 | Feb 9, 2016 · 8:07 pm EST | Form 4 |
| CPEChina Fund, L.P.10% Owner | 19,601,138 | — | 19,601,138 | Feb 9, 2016 · 8:07 pm EST | Form 4 |
| CITIC PE Funds Ltd10% Owner | 19,601,138 | — | 19,601,138 | Feb 9, 2016 · 8:07 pm EST | Form 4 |
| CITIC PE Associates, L.P.10% Owner | 19,601,138 | — | 19,601,138 | Feb 9, 2016 · 8:07 pm EST | Form 4 |
| Baker Bros. Advisors (GP) LLCDirector | 10,418 | 8,068,411 | 8,078,829 | Jun 15, 2026 · 4:38 pm EDT | Form 4 |
| 667, L.P.Director | 10,418 | 8,068,411 | 8,078,829 | Jun 15, 2026 · 4:38 pm EDT | Form 4 |
| Baker Brothers Life Sciences LPDirector | 10,418 | 8,068,411 | 8,078,829 | Jun 15, 2026 · 4:38 pm EDT | Form 4 |
| BAKER BROS. ADVISORS LPDirector | 10,418 | 8,068,411 | 8,078,829 | Jun 15, 2026 · 4:38 pm EDT | Form 4 |
| Felix BakerDirector | 10,418 | 8,068,411 | 8,078,829 | Jun 15, 2026 · 4:38 pm EDT | Form 4 |
| Julian BakerDirector | 10,418 | 8,068,411 | 8,078,829 | Jun 15, 2026 · 4:38 pm EDT | Form 4 |
| Merck Sharp & Dohme Research GmbH10% Owner | — | 7,942,314 | 7,942,314 | Feb 10, 2016 · 4:28 pm EST | Form 4 |
| Merck Sharp & Dohme Corp.10% Owner | — | 7,942,314 | 7,942,314 | Feb 10, 2016 · 4:28 pm EST | Form 4 |
| Merck & Co., Inc.10% Owner | — | 7,942,314 | 7,942,314 | Feb 10, 2016 · 4:28 pm EST | Form 4 |
| Xiaodong WangDirector | 4,588,113 | 50 | 4,588,163 | Sep 10, 2026 · 4:49 pm EDT | Form 4 |
| 14159, L.P.Director | 7,102 | 3,476,256 | 3,483,358 | Oct 16, 2017 · 5:47 pm EDT | Form 4 |
| Lai WangPresident, Global Head of R&D | 1,681,004 | 0 | 1,681,004 | Jun 25, 2026 · 5:14 pm EDT | Form 4 |
| John OylerChief Executive Officer | 1,330,988 | 102,188 | 1,433,176 | Aug 12, 2026 · 5:53 pm EDT | Form 4 |
| Ji LiEVP and Gl. Head of Bus. Dev. | 475,000 | — | 475,000 | Mar 2, 2018 · 6:41 pm EST | Form 4 |
| Aaron RosenbergChief Financial Officer | 382,850 | — | 382,850 | Aug 5, 2026 · 5:15 pm EDT | Form 4 |
| Chan Henry LeeSVP, General Counsel | 325,312 | — | 325,312 | Aug 13, 2026 · 8:54 pm EDT | Form 4 |
| Jane HuangCMO, Hematology | 271,621 | 0 | 271,621 | Mar 11, 2019 · 7:38 pm EDT | Form 4 |
| Jianxin YangSr. VP, Head of Clinical Dev. | 200,000 | — | 200,000 | Feb 2, 2016 · 7:06 pm EST | Form 3 |
| Amy C. PetersonCMO, Immuno-oncology | 194,569 | — | 194,569 | Dec 19, 2018 · 6:34 pm EST | Form 4 |
| RuiRong YuanChief Medical Officer | 130,000 | — | 130,000 | Feb 9, 2016 · 8:08 pm EST | Form 4 |
| Titus B. BallPrincipal Accounting Officer | 97,929 | — | 97,929 | Sep 3, 2026 · 5:17 pm EDT | Form 4 |
| Anthony C HooperDirector | 83,720 | — | 83,720 | Jun 15, 2026 · 5:50 pm EDT | Form 4 |
| Margaret DuganDirector | 73,164 | — | 73,164 | Jun 15, 2026 · 5:50 pm EDT | Form 4 |
| Alessandro RivaDirector | 73,164 | — | 73,164 | Jun 15, 2026 · 5:49 pm EDT | Form 4 |
| Howard LiangCFO & Chief Strategy Officer | 52,338 | — | 52,338 | Jun 28, 2018 · 7:43 pm EDT | Form 4 |
| Donald W. GlazerDirector | 13,384 | 38,160 | 51,544 | Nov 21, 2018 · 6:42 pm EST | Form 4 |
| Olivier BrandicourtDirector | 46,306 | — | 46,306 | Jun 15, 2026 · 5:51 pm EDT | Form 4 |
| Thomas MalleyDirector | 30,000 | — | 30,000 | Jun 8, 2018 · 5:50 pm EDT | Form 4 |
| Qingqing YiDirector | 24,271 | — | 24,271 | Jun 3, 2026 · 4:10 pm EDT | Form 4 |
| Elizabeth Fisher MooneyDirector | 18,980 | — | 18,980 | Jun 15, 2026 · 5:50 pm EDT | Form 4 |
| Xiaobin WuPresident and COO | 12,365 | 4,000 | 16,365 | Aug 27, 2026 · 5:12 pm EDT | Form 4 |
| Timothy Yung-Cheng ChenDirector | 9,290 | — | 9,290 | Jun 8, 2018 · 5:50 pm EDT | Form 4 |
| Charles Lazelle SawyersDirector | 1,946 | — | 1,946 | Jun 15, 2026 · 5:49 pm EDT | Form 4 |
| Shalini SharpDirector | 9 | — | 9 | Jun 15, 2026 · 5:49 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.